Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial
The efficacy and tolerability of a fixed combination of 160 mg sabal fruit extract WS 1473 and 120 mg urtica root extract WS 1031 per capsule (PRO 160/120) was investigated in elderly, male patients… Expand
Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms—long-term follow-up of a placebo-controlled, double-blind, multicenter trial
- N. Lopatkin, A. Sivkov, S. Schläfke, P. Funk, A. Medvedev, U. Engelmann
- International Urology and Nephrology
- 15 February 2007
In an open-label extension of a randomized, double-blind clinical trial, the long-term efficacy and tolerability of a fixed combination of 160 mg Sabal fruit extract WS 1473 and 120 mg Urtica root… Expand
Long-term clinical and biologic effects of the lipidosterolic extract ofSerenoa repens in patients with symptomatic benign prostatic hyperplasia
Permixon®, the lipidosterolic extract ofSerenoa repens, is widely used for the treatment of symptoms associated with benign prostatic hyperplasia (BPH). This open study assessed the efficacy and… Expand
An endourologic approach to complete ureteropelvic junction and ureteral strictures.
BACKGROUND AND PURPOSE Complete stricture of the ureteropelvic junction (UPJ), ureter, or both represents a secondary upper tract obstruction and is a challenge for surgical management. The… Expand
Essential renal haemorrhages.
On the basis of the conception of renal hypertension, worked out by the authors, the new interpretation of the cause of 'essential' renal haemorrhages is discussed. Special attention is drawn to… Expand
Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia.
- Y. A. Pytel', A. Vinarov, N. Lopatkin, A. Sivkov, L. Gorilovsky, J. Raynaud
- Advances in therapy
Permixon, the lipidosterolic extract of Serenoa repens, is widely used for the treatment of symptoms associated with benign prostatic hyperplasia (BPH). This open study assessed the efficacy and… Expand
Nephrectomy with prior intraluminal balloon occlusion of the renal artery in kidney cancer.
[Fluorescent diagnostics of urinary bladder cancer].
Introduction of optic markers in screening for cancer of the urinary bladder (UB) raises diagnostic significance of UB cystoscopy. Application of intravesical form of 5-aminolevulinic acid (5-ALA),… Expand
[Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial].
A multicenter, prospective clinical trial was performed to study efficacy and tolerance of a compound drug PRO 160/120 in the elderly men with lower urinary tract symptoms (LUTS) due to benign… Expand
[The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia].
- I. Pytel', N. Lopatkin, L. M. Gorilovskii, A. Vinarov, A. Sivkov, A. Medvedev
- 1 March 2004
The trial enrolled 155 patients (mean age 65 years) with documented benign prostatic hyperplasia and lower urinary tracts symptoms (LUTS) (IPSS > 6). All the patients received permixon in a dose 160… Expand